RETASPIMYCIN
UNII BZF2ZM0I5Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Retaspimycin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BZF2ZM0I5Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 857402-23-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

BZF2ZM0I5Z

CAS Registry Number

857402-23-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RETASPIMYCIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C31H45N3O8

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

OAKGNIRUXAZDQF-TXHRRWQRSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C80378

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

11534420

Unique identification number in the NCBI database of chemical substances.

INN ID

9000

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

TT-114

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(cc2NC(/C(=C/C=C\[C@H](OC)[C@@H](OC(N)=O)/C(=C/[C@@H]([C@@H](O)[C@H](C[C@@H](Cc(c1NCC=C)c2O)C)OC)C)/C)/C)=O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Retaspimycin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.